EMulate Therapeutics, Inc.

Industry

  • Medical Devices
    • Radiofrequency Devices

Other Names/Subsidiaries

  • Nativis, Inc.
  • Indolor Therapeutics, Inc.
  • Mensana Therapeutics, Inc.
  • Cellsana Therapeutics, Inc.
See more in Biomedtracker

Latest on EMulate Therapeutics, Inc.

Scrip

VC Roundup: October Brings Several New Venture Funds, Including Third Rock’s Fourth

 
• By Mandy Jackson

Third Rock Ventures has raised its fourth and largest venture capital fund at $616m, joining at least three other groups that closed new life science-focused VC and debt funds in October for a total

In Vivo

Deals Shaping the Medical Industry, August 2016

 
• By Beth Allan, Deanna Kamienski, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS Alliances Cleveland HeartLab LLC Global Discovery Biosciences Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS ( Prote

Scrip

Deal Watch: Flagship Ventures Doubles Down On Microbiome

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between July 8-13. Deal Watc

Scrip

Start-Up Quarterly Statistics, Q1 2016

 
• By Deanna Kamienski

Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3